Connection: our innovative concept

At the core of our innovative connection-based concept, our qualifying approach generates as much information as possible about the pharmacological behavior of a molecule. With this approach, Oncodesign aims to optimally position each molecule towards a disease indication and a patient population, in order to maximize its value.

For this reason, the purpose of our technological platforms and processes is to qualify the therapeutic potential of molecules in addressing pertinent biological questions so that we can:

• Orient their development towards the right patient targets
• Innovate with relevant solutions
• Create value by developing the potential of each drug candidate.

From a business perspective, our experimentation service activity provides us with the experience, expertise and financial resources that enable us to maintain and develop our platforms and our pharmacological focus dedicated to the discovery of innovative molecules.